Insider Transactions Reported by 21 Insiders of NRX Pharmaceuticals, Inc.

Symbol
NRXP, NRXPW on Nasdaq
Location
Wilmington, DE

There are no Buy or Sell transactions made by insiders since 07 Feb 2025

NRX Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
B Group, Inc. 10%+ Owner $7,560,000 18 Aug 2025
Daniel Javitt 10%+ Owner $3,082,170 29 Nov 2022
Jonathan Javitt Chairman and Chief Scientist, Director, 10%+ Owner $1,774,696 09 Apr 2025
Big Rock Partners Sponsor, LLC 10%+ Owner $266,129 24 May 2021
BRAC Lending Group LLC 10%+ Owner $188,880 24 May 2021
Robert Besthof Interim CEO $57,025 08 Mar 2022
William Fricker CFO & Treasurer $39,680 24 May 2021
Aaron Gorovitz Director $33,590 30 Aug 2023
Daniel Troy Director $26,872 24 May 2021
Stephen Willard CHIEF EXECUTIVE OFFICER, Director $15,995 16 Dec 2022
Alessandra Daigneault General Counsel & Secretary $15,891 19 Aug 2021
Seth Van Voorhees Chief Financial Officer $14,823 16 Dec 2022
Michael Abrams Chief Financial Officer $10,000 07 Feb 2025
Herbert Raymond McMaster Director $9,126 26 Aug 2021
Chaim Hurvitz Director 09 Apr 2025
Sharon A. Glied Director 21 Oct 2022
Patrick Flynn Director 09 Apr 2025
Ira S. Strassberg Chief Financial Officer 15 Mar 2022
Janet Rehnquist Director 28 Dec 2023
Dennis McBride Director 09 Apr 2025
s/ Richard Narido Interim CFO 13 Sep 2023

Recent Insider Transactions by Companies or Individuals for NRX Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.